Prevalence of dangerous arrhythmia during pharmacological stress echocardiography;Czȩsfość wystȩpowania groźnych zaburzeń rytmu podczas farmakologicznej echokardiografii obcia̧żeniowej

Polski Merkuriusz Lekarski

Volumn 20, Issue 120, 2006, Pages 635-638

  Wejner Mik, Paulina ^a   Drozdz, J ^a   Lipiec, P ^a   Krzeminska Pakula M ^a   Ciesielczyk, M ^a   Kasprzak, J D ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Adverse effects; Arrhythmia; Pharmacological stress echocardiography; Safety

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE; DOBUTAMINE; ADRENERGIC RECEPTOR STIMULATING AGENT; CARDIOTONIC AGENT; DIAGNOSTIC AGENT; VASODILATOR AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG MEGADOSE; DRUG SAFETY; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PHARMACOLOGIC STRESS TESTING; PREVALENCE; FEMALE; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; STRESS ECHOCARDIOGRAPHY;

ARRHYTHMIA; ATROPINE; CARDIOTONIC AGENTS; DIPYRIDAMOLE; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SYMPATHOMIMETICS; VASODILATOR AGENTS;

EID: 33746156981     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bountioukos M., Kertai M.D., Schinkel A.F. i wsp.: Safety of dobutamine stress echocardiography in patients with aortic stenosis. J. Heart Valve Dis., 2003, 12, 441-6.
2. Cortigiani L., Picano E., Colletta C. i wsp.: Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting. Am. Heart J., 2001, 141, 621-9.
3. Dal Porto R., Faletra F., Picano E. i wsp.: Safety, feasibility, and diagnostic accuracy of accelerated high-dose dipyridamole stress echocardiography. Am. J. Cardiol., 2001, 87, 520-4.
4. Echokardiografia obcia̧żeniowa. Stress echo, Volumed, Opole 2004.
5. Fleischmann K.E., Hunink M.G., Kuntz K.M. i wsp.: Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA, 1998, 280, 913-20.
6. Gackowski A., Płońska E.: Echokardiografia obcia̧żeniowa. Echokardiografia. Red. Hoffman P., Kasprzak J.D., Volumed, Gdańsk 2004.
7. Kopff A., Drożdż J., Kasprzak J.D.: Echokardiograficzna próba dipirydamolowa. Pol. Przegl. Kardiol. 2004, 6, 329-34.
8. Lowenstein J., Varga A., Rodriquez G.M.A. i wsp.: Safety of stress echocardiography. The results of the international stress echo complication registry. Echocardiography, 2004, 21, 208.
9. Marwick T.H.: Stress echocardiography. Heart, 2003, 89, 113-8.
10. Mathias W Jr, Arruda A., Santos F.C. i wsp.: Safety of dobutamine-atropine stress echocardiography: A prospective experience of 4033 consecutive studies. J. Am. Soc. Echocardiogr., 1999, 12, 785-91.
11. Minardi G., Manzara C.C., Pulignano G. i wsp.: Safety and diagnostic accuracy of intravenous accelerated high-dose dipirydamole-atropine stress echocardiography. Ital. Heart J., 2003, 3, 726-9.
12. Picano E., Mathias W. Jr, Pingitore A. i wsp.: Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. Lancet, 1994, 344, 1190-2.
13. Płonska E., Ga̧sior Z., Szyszka A. i wsp.: Safety of stress echocardiography with dobutamine used in patients with aortic stenosis and left ventricular dysfunction. Przegl. Lek., 2002, 59, 668-71.
14. Płońska E., Szwed H, Ga̧sior Z. i wsp.: Side effects during dobutamine stress echocardiography: analysis of 582 studies. Pol. Merkuriusz Lek., 1999, 7, 164-8.
15. Płońska E., Szyszka A., Kasprzak J.D. i wsp.: Side effects during dobutamine stress echocardiography in patients with aortic stenosis. Pol. Merkuriusz Lek., 2001, 11, 406-10.
16. Secknus M.A., Marwick T.H.: Evolution of dobutamine echocadiography protocols and indications: safety and side efects in 3011 studies over 5 years. J. Am. Coll. Cardiol., 1997, 29, 1234.
17. Tak T., Gutierrez R.: Comparing stress testing methods. Available techniques and their use in CAD evaluation. Postgrad. Med., 2004, 115, 61-70.
18. Tsutsui J.M., Elhendy A., Xie F. i wsp.: Safety of dobutamine stress real-time myocardial contrast echocardiography. J. Am. Coll. Cardiol. 2005, 45, 1235-42
19. Wejner-Mik P., Lipiec P., Ciesielczyk M. i wsp.: Novel, rapid protocol of dipyridamole/atropine stress echocardiography. Vl Srodkowoeuropejska Konferencja Echokardiograficzna, Szczecin, 14-15.10.2005.